Mammalian skeletogenesis and extracellular matrix: What can we learn from knockout mice?

Cell Structure and Function

Volumn 25, Issue 2, 2000, Pages 73-84

  Aszódi, Attila ^a   Bateman, John F ^b   Gustafsson, Erika ^a   Boot Handford, Ray ^a,c   Fässler, Reinhard ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Extracellular matrix; Knockout mice; Skeletal disorders; Skeletogenesis

Indexed keywords

COLLAGEN TYPE 2; COLLAGEN TYPE 9; FIBROMODULIN; PERLECAN; SCLEROPROTEIN; TENASCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; GENE MUTATION; GENETIC DISORDER; HUMAN; KNOCKOUT MOUSE; MAMMAL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BONE DEVELOPMENT; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCULOSKELETAL ABNORMALITIES; MUTATION; PHENOTYPE;

ANIMALIA; MAMMALIA; MUS MUSCULUS; VERTEBRATA;

EID: 0033922216     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.25.73     Document Type: Article

References (69)

1. Annunen S., Paassilta, P., Lohiniva, J., Perälä, M., Plihkajamaa, T., Karppinen, J., Tervonen, O., Kröger, H., Lähde, S., Vanharanta, H., Ryhänen, L., Göring, H.H.H., Ott, J., Prockop, D.J., and Ala-Kokko, L. 1999. An allele of COL9A associated with intervertebral disc disease. Science, 285:409-412.
2. Arikawa-Hirasaw, A.E., Watanabe, H., Takami, H., Hassell, J.R., and Yamada, Y. 1999. Perlecan is essential for cartilage and cephalic development. Nat. Genet., 23: 354-358.
3. Aszódi A., Hauser, N., Studer, D., Paulsson, M., Hiripi, L., and Bösze, Z. 1996. Cloning, sequencing and expression analysis of mouse cartilage matrix protein cDNA. Eur. J. Biochem., 236: 970-977.
4. Aszódi, A., Chan, D., Hunziker, E., Bateman, J.F., and Fässler, R. 1998a. Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. J. Cell Biol., 143: 1399-1412.
5. Aszódi, A., Beier, D., Hiripi, D., Bösze, Z., and Fässler, R. 1998b. Sequence, structure and chromosomal localization of Crtm gene encoding mouse cartilage matrix protein and its exclusion as a candidate for murine achondroplasia. Matrix Biol., 16: 563-573.
6. Aszódi, A., Pfeifer, A., Wendel, M., Hiripi, L., and Fässler, R. 1998c. Mouse models for extracellular matrix diseases. J. Mol. Med., 76: 238-252.
7. Aszódi, A., Bateman, J.F., Hirsch, E., Baranyi, M., Hunziker, E.B., Hauser, N., Bösze, Z., and Fässler, R. 1999. Normal skeletal development of mice lacking matrilin 1: redundant function of matrilins in cartilage? Mol. Cell Biol., 19: 7841-7845.
8. Aviezer, A., Hecht, D., Safran, M., Eisnger, M., David, G. and Yaynon, A. 1994. Perlecan, basal lamina proteoglycan, promotes basoc fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell, 79: 1005-1013.
9. Benya, P.D. and Shaffer, J.D. 1982. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell, 30: 215-224.
10. Bianco, P., Cancedda, F.D., Riminucci, M. and Cancedda, R. 1998. Bone formation via cartilage models: the "borderline" chondrocyte. Matrix Biol., 17: 185-192.
11. Bruckner, P. and van der Rest, M. 1994. Structure and function of cartilage collagens. Microsc. Res. Technique, 28: 378-384.
12. Chakravarty, S., Magnuson, T., Lass, J.H, Jepsen, K.J., LaMantia, C., and Carrol, H. 1998. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell Biol., 141: 1277-1286.
13. Chan, D., Cole, W.G,. Chow, C. W, Mundlos, S., and Bateman, J.F. 1995. A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage. J. Biol. Chem., 270: 1747-1753.
14. 2 mutants and activin stimulation. In Limb Development and Regeneration (J.F. Fallon, P.F. Goetinck, R.O. Kelley, and D.L. Stocum, eds.). Wiley-Liss, New York, pp. 465-474.
15. Costell, M., Gustafsson, E., Aszódi A., Mörgelin, M., Bloch, W., Hunziker, E., Addicks, K., Timpl, R., and Fässler, R. 1999. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol., 147: 1109-1122.
16. Danielson, K.G., Baribault, H., Holmes, D.F., Graham, H., Kadler, K.E., and Iozzo, R.V. 1997. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol., 136: 729-743.
17. Deák, F., Wagener, R., Kiss, I., and PauLsson, M. 1999. The matrilins: a novel family of oligomeric extracellular matrix proteins. Matrix Biol., 18: 55-64.
18. Dessau, W., von der Mark, H., von der Mark, K., and Fischer, S. 1980. Changes in the patterns of collagens and fibronectin during limb-bud chondrogenesis. J. Embryol. Exp. Morph., 57: 51-60.
19. Diab, M., Wu, J.J., and Eyre, D.R. 1996. Collagen type DX from human cartilage: a structural profile of intermolecular cross-linking sites. Biochem. J., 314: 327-332.
20. Erlebacher, A., Filvaroff, E.H., Gitelman, S.E., and Derynck, R. 1995. Toward a molecular understanding of skeletal development. Cell, 80: 371-378.
21. Eyre, D.R., Apon, S., Wu, J.J., Ericsson, L.H., and Walsh, K.A. 1987. Collagen type IX: evidence for covalent linkages to type II collagen in cartilage. FEBS Lett., 220: 337-341.
22. Fässler, R., Schnegelsberg, P.N.J., Dausman, J., Shinya, T., Muragaki, Y., McCarthy, M.T., Olsen, B.R., and Jaenisch, R. 1994. Mice lacking α1(IX) collagen develop noninflammatory degenerative joint disease. Proc. Natl. Acad. Sci. USA, 91: 5070-5074.
23. Forsberg, E., Hirsch E., Fröhlich, L., Meyer, M., Ekblom, P., Aazódi, A., Werner, S., and Fässler, R. 1996. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc. Natl. Acad. Sci. USA, 93: 6594-6599.
24. French, M.M., Smith, S.E., Akanbi, K., Sanford, T., Hecht, J., Farach-Carson, M.C., and Carson, D.D. 1999. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J. Cell Biol., 145: 1103-1115.
25. Gupta-Bansal, R., Frederickson, R.C., and Brunden, K.R. 1995. Proteoglycan-mediated inhibition of Aβ proteolysis. A potential cause of senile plaque accumulation. J Biol. Chem., 270: 18666-18671.
26. Hagg, R., Hedbom, E., Möllers, U., Aszódi, A., Fässler, R., and Bruckner, P. 1997. Absence of the α1(IX) chain leads to a functional knock-out of the entire collagen IX protein in mice. J. Biol. Chem., 272: 20650-20654.
27. Handler, M., Yurchenco, P.D., and Iozzo, R.V. 1997. Developmental expression of perlecan during murine embryogenesis. Dev. Dyn., 210: 130-145.
28. Hassell, J.R., Gehron-Robey, P., Barrach, H.-J., Wilczek, J., Rennard, S.I., and Martin, G.R. 1980. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc. Natl. Acad. Sci. USA, 77: 4494-4498.
29. Hauser, N., Paulsson M., Heinegård, D., and Mörgelin, M. 1996. Interaction of cartilage matrix protein (CMP) with aggrecan, Increased covalent crosslinking with maturation. J. Biol. Chem., 271: 32247-32252.
30. Holden, P., Canty E.G., Mortier, G.R., Zabel, B., Spranger, J., Carr, A., Grant, M.E., Loughlin, J.A., and Briggs, M.D. 1999. Identification of novel pro-alpha2(IX) collagen gene mutations in two families with distinctive oligo-epiphyseal forms of multiple epiphyseal dysplasia. Am. J. Hum. Genet., 65:31-38.
31. Horton, W.A. 1993. Morphology of connective tissue: cartilage. In Connective Tissue and its Heritable Disorders. Molecular, Genetic, and Medical Aspects (P.M. Royce, and B. Steinmann, eds.). Wiley-Liss, Inc., New York, pp. 73-84.
32. Bunziker, E.B., Hermann, W., Schenk, R.K., Mueller, M., and Moor, H. 1984. Cartilage ultrastructure after high pressure freezing, freeze substitution, and low temperature embedding. I. Chondrocyte ultrastructure. Implications for the theories of mineralization and vascular invasion. J. Cell Biol., 98: 267-276.
33. Hunziker, E.B., Schenk, R.K., and Cruz-Orive, L-M. 1987. Quantitation of chondrocyte performance in growth plate cartilage during longitudinal bone growth. J. Bone Joint Surg., 69: 162-173.
34. Hunziker, E.B. 1994. Mechanism of longitudinal bone and its regulation by growth plate chondrocyte. Microsc. Res. Technol., 28: 505-519.
35. Hynes, R.O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69: 11-25.
36. Iozzo, R. V. 1999. The biology of the small leucine-rich proteoglycans. J. Biol. Chem., 274: 18843-18846.
37. Kern P., Menasche, M., and Robert, L. 1991. Relative rates of biosynthesis of collagen type I, type V and type VI in calf cornea. Biochem.J., 274: 615-617.
38. Kielty, C.M., Hopkinson, I., and Grant M.E. 1993. Collagen. The collagen family: structure, assembly, and organization in the extracellular matrix. In Connective Tissue and its Heritable Disorders. Molecular, Genetic, and Medical Aspects (P.M. Royce, and B. Steinmann, eds.). Wiley-Liss, Inc., New York, pp. 103-147.
39. Kimura, T., Nakata, K., Tsumaki, N., Miyamoto, S., Matsui, Y., Ebara, S., and Ochi, T. 1996. Progressive degeneration of articular cartilage and intervertebral discs. An experimental study in transgenic mice bearing a type IX collagen mutation. Int. Orthop., 20: 177-181.
40. Kuivaniemi, H., Tromp, G., and Prockop, D.J. 1991. Mutations in collagen genes: causes of rare and some common diseases in humans. FASEB J., 5: 2052-2060.
41. Li, S.W., Prockop, D.J., Helminen, H., Fässler, R., Lapveteläinen, T., Kiraly, K., Peltarri, A., Arakoski, J., Lui, H., Arita, M., and Khillan, J.S. 1995. Transgenic mice with targeted inactivation of the Col2α1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes. Dev., 9: 2821-2830.
42. Mackie, E.J. Thesleff, I., and Chiquet-Ehrismann, R. 1987. Tenascin-C is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J. Cell Biol., 105: 2569-2579.
43. Mackie, E.J. and Murphy, L.I. 1998. The role of tenascin-C and related glycoproteins in early chondrogenesis. Microsc. Res. Tech., 15: 102-110.
44. Mackie, E.J. and Tucker, R.P. 1999. The tenascin-C knockout revisited. J. Cell Sci., 112: 3847-3853.
45. McCormick, D., van der Rest, M., Goodship, J., Lozano, G., Ninomiya, Y., and Olsen, B.R. 1987. Structure of the glycosaminoglycan domain in the type IX collagen-proteoglycan. Proc. Natl. Acad. Sci. USA, 84: 4044-4048.
46. 913 to Cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogenesis. Am. J. Med. Genet., 63: 129-136.
47. Mundlos, S. and Olsen, B.R. 1997a. Heritable diseases of the skeleton. Part I: molecular insight into skeletal development-transcription factors and signaling pathways. FASEB J., 11: 125-132.
48. Mundlos, S. and Olsen, B.R. 1997b. Heritable diseases of the skeleton. Part II: molecular insight into skeletal development-matrix components and their homeostasis. FASEB J., 11: 227-233.
49. Muragaki, Y., Mariman, E.C.M., van Beersum, S.E.C., Peräla, M., van Mourik, J.B.A., Warman, M.L., Olsen, B.R., and Hamel, B.J.C. 1996. A mutation in the gene encoding the α2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nat. Genet., 12: 103-105.
50. Murdoh, A.D., Liu, B., Schwarting, R., Tuan, R.S., and Iozzo, R. V. 1994. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem., 42: 239-249.
51. Nakata, K., Ono, K., Miyazaki, J.I., Olsen, B.R., Muragaki, Y., Adachi, E., Yamamura, K.I., and Kimura, T. 1993. Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing α1-(IX) collagen , chains with a central deletion. Proc. Natl. Acad. Sci. USA, 90: 2870-2874.
52. Neame, P.J., Tapp, H., and Azizan, A. 1999. Noncollagenous, nonproteoglycan macromolecules of cartilage. Cell Mol. Life Sci., 55: 1327-1340.
53. Nishimura , I., Muragaki, Y., and Olsen, B.R. 1989. Tissue specific forms of type IX collagen-proteoglycan arise from the use of two widely separated promoters. J. Biol. Chem., 264: 20033-20041.
54. Paassilta, P., Lohiniva, J., Annunen, S., Bonaventure, J., Le Merrer, M., Pai, L., and Ala-Kokko, L. 1999. COL9A3: a third locus for multiple epiphyseal dysplasia. Am. J. Hum. Genet., 64: 1036-1044.
55. Pacifici, M., Iwamoto, M., Golden, E.B., Leatherman, J.L. Lee, Y.-S. and Chuong, C.-M. 1993. Tenascin is associated with articular cartilage development. Dev. Dyn., 198: 123-134.
56. Pacifici, M. 1994. Tenascin-C and the development of articular cartilage. Matrix Biol., 14: 689-698.
57. Roughley, P.J. and Lee, E.R. 1994. Cartilage proteoglycans: structure and potential functions. Microsc. Res. Technol., 28: 385-397.
58. Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T., and Aizawa, S. 1992. Mice develop normally without tenascin. Genes. Dev., 6: 1821-1831.
59. Schenk, R.K., Felix, R., and Hofstetter, W. 1993. Morphology of connective tissue: bone. In Connective Tissue and its Heritable Disorders. Molecular, Genetic, and Medical Aspects (P.M. Royce, and B. Steinmann, eds.). Wiley-Liss, Inc., New York, pp. 85-101.
60. Shapiro, F., Holtrop, M.E., and Glimcher, M.J. 1977. Organization and cellular biology of the perichondrial ossification groove of Ranvier. J. Bone Joint Surg., 59-A: 703-723.
61. Svensson, L., Aszódi, A., Reinholt, F.P., Fässler, R., Heinegård, D., and Oldberg, Å. 1999. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization and altered lumican deposition in tendon. J. Biol. Chem., 274: 9636-9647.
62. Talts, J.F., Wirl, G., Dictor, M., Müller, W.J., and Fässler, R. 1999. Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. J. Cell Sci., 112: 1855-1864.
63. Vanky, P., Brockstedt, U., Hjerpe, A., and Wikstrom, B. 1998. Kinetic studies on epiphyseal growth cartilage in the normal mouse. Bone, 22: 331-339.
64. Vogel, K.G and Trotter, J.A. 1987. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Coll. Relat. Res., 7: 105-114.
65. Wagener, R., Kobbe, B., and Paulsson, M. 1997. Primary structure of matrilin-3 gene, a new member of a family of extracellular matrix proteins related to cartilage matrix protein (matrilin-1) and von Willebrand factor. FEBS Lett., 413: 129-134.
66. Wagener, R., Kobbe, B., Aszódi, A., Liu, Z., Beier, D.R., and Paulsson, M. 2000. Structure and mapping of the mouse matrilin-3 gene (Matn3), a member of a gene family containing a U12-type AT-AC intron. Mamm. Genome, 11: 85-90
67. Winterbottom, N., Tondravi, M.M., Harrington, T.L., Klier, F.G, Vertel, B.M., and Goetinck, P.P. 1992. Cartilage matrix protein is a component of the collagen fibril of cartilage. Dev. Dyn., 193: 266-276.
68. Wu, J.J., Woods, P.E., and Eyre, D.R. 1992. Identification of cross-linking sites in bovine cartilage type IX collagen reveals an antiparallel type II-type IX molecular relationship and type IX to type IX bonding. J. Biol. Chem., 267:23007-23014.
69. Wu, J.J. and Eyre, D.R. 1998. Matrilin-3 forms disulfide-linked oligomers with matrilin-1 in bovine epyphyseal cartilage. J. Biol. Chem., 273: 17433-17438.